We believe you may hold MRK stock, as the company has one of the world's best-selling drugs in its portfolio that generates ...

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

The "Global Cancer Vaccines Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's ...

Moderna shares slid -12.4% this morning. Here's what you need to know about the Large-CapBiotechnology company: Moderna has logged a -39.2% 52 week change, compared to 25.7% for the S&P 500 MRNA has ...

("Moderna" or "the Company") (NASDAQ: MRNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange ...

This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way.

As of 2024, there are three COVID-19 vaccines approved for use by the U.S. Food and Drug Administration (FDA): Pfizer-BioNTech (marketed under the brand name Comirnaty), an mRNA vaccine Moderna ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other Jim Cramer stocks that finished dead last. In a recent episode of Mad Money, Jim Cramer ...

Aaron Rodgers is no stranger to facing the Minnesota Vikings. On Sunday, the New York Jets quarterback will start his 30th game against the Vikings, tied for his most versus any opponent. The ...

The deal marks 10-year-old Moderna’s first acquisition. The company develops mRNA therapeutics and vaccines, and the move will enable it to utilise the synthetic biology and enzyme tech of 2018 ...